Page last updated: 2024-08-17

ethinyl estradiol and Abnormality, Heart

ethinyl estradiol has been researched along with Abnormality, Heart in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (33.33)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Cereijo, R; de Zegher, F; García-Beltran, C; Ibáñez, L; López-Bermejo, A; Malpique, R; Quesada-López, T; Villarroya, F	1
Brook, CG; Hindmarsh, PC; Nathwani, NC; Unwin, R	1
Oakley, C; Somerville, J	1

Trials

1 trial(s) available for ethinyl estradiol and Abnormality, Heart

Article	Year
Reduced circulating levels of chemokine CXCL14 in adolescent girls with polycystic ovary syndrome: normalization after insulin sensitization. BMJ open diabetes research & care, 2020, Volume: 8, Issue:1 Topics: Adipocytes; Adipogenesis; Adipose Tissue, Brown; Adolescent; Arrhythmias, Cardiac; Biomarkers; Chemokines, CXC; Contraceptives, Oral, Hormonal; Drug Therapy, Combination; Ethinyl Estradiol; Female; Gene Expression; Genetic Diseases, X-Linked; Gigantism; Heart Defects, Congenital; Humans; Hypoglycemic Agents; Insulin Resistance; Intellectual Disability; Levonorgestrel; Metformin; Mineralocorticoid Receptor Antagonists; Pioglitazone; Polycystic Ovary Syndrome; Spironolactone; Treatment Outcome	2020

Article

Year

Reduced circulating levels of chemokine CXCL14 in adolescent girls with polycystic ovary syndrome: normalization after insulin sensitization.

BMJ open diabetes research & care, 2020, Volume: 8, Issue:1

Topics: Adipocytes; Adipogenesis; Adipose Tissue, Brown; Adolescent; Arrhythmias, Cardiac; Biomarkers; Chemokines, CXC; Contraceptives, Oral, Hormonal; Drug Therapy, Combination; Ethinyl Estradiol; Female; Gene Expression; Genetic Diseases, X-Linked; Gigantism; Heart Defects, Congenital; Humans; Hypoglycemic Agents; Insulin Resistance; Intellectual Disability; Levonorgestrel; Metformin; Mineralocorticoid Receptor Antagonists; Pioglitazone; Polycystic Ovary Syndrome; Spironolactone; Treatment Outcome

2020

Other Studies

2 other study(ies) available for ethinyl estradiol and Abnormality, Heart

Article	Year
The influence of renal and cardiovascular abnormalities on blood pressure in Turner syndrome. Clinical endocrinology, 2000, Volume: 52, Issue:3 Topics: Adolescent; Adult; Anabolic Agents; Analysis of Variance; Blood Pressure Monitoring, Ambulatory; Child; Child, Preschool; Cross-Sectional Studies; Drug Therapy, Combination; Ethinyl Estradiol; Female; Growth Hormone; Heart Defects, Congenital; Humans; Hypertension; Kidney; Oxandrolone; Prevalence; Progesterone; Renin; Turner Syndrome	2000
Oral contraceptives and progressive pulmonary vascular disease. Lancet (London, England), 1968, Apr-27, Volume: 1, Issue:7548 Topics: Adult; Cardiovascular Diseases; Contraceptives, Oral; Ethinyl Estradiol; Female; Heart Defects, Congenital; Humans; Lynestrenol; Mestranol; Norethindrone; Norethynodrel; Pregnancy; Pulmonary Circulation	1968

Article

Year

The influence of renal and cardiovascular abnormalities on blood pressure in Turner syndrome.

Clinical endocrinology, 2000, Volume: 52, Issue:3

Topics: Adolescent; Adult; Anabolic Agents; Analysis of Variance; Blood Pressure Monitoring, Ambulatory; Child; Child, Preschool; Cross-Sectional Studies; Drug Therapy, Combination; Ethinyl Estradiol; Female; Growth Hormone; Heart Defects, Congenital; Humans; Hypertension; Kidney; Oxandrolone; Prevalence; Progesterone; Renin; Turner Syndrome

2000

Oral contraceptives and progressive pulmonary vascular disease.

Lancet (London, England), 1968, Apr-27, Volume: 1, Issue:7548

Topics: Adult; Cardiovascular Diseases; Contraceptives, Oral; Ethinyl Estradiol; Female; Heart Defects, Congenital; Humans; Lynestrenol; Mestranol; Norethindrone; Norethynodrel; Pregnancy; Pulmonary Circulation

1968